Luís Meza
Impact in
- Oncology top 5%
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Erythropoietin and Anemia Treatment
Papers in
- Oncology 46
- Cancer Immunotherapy and Biomarkers 21
- Pancreatic and Hepatic Oncology Research 11
-
- Renal cell carcinoma treatment 43
- Co-authors
- John A. GlaspyBertrand C. LiangFrankie A. HolmesMichael A. SavinJoyce O’ShaughnessyStephen E. JonesTheresa NeumannJ. Shogan
- Journals
- Journal of Clinical Oncology (29 papers)The Oncologist (5 papers)Clinical Genitourinary Cancer (4 papers)Annals of Oncology (4 papers)European Journal of Cancer (2 papers)
- Partner nations
- United StatesCanadaDenmark
In The Last Decade
Luís Meza
75 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 85
- Oncology 951
- Hematology 294
- Dermatology 165
- Genetics 500
- Clinical Biochemistry 88
Countries citing papers authored by Luís Meza
This map shows the geographic impact of Luís Meza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís Meza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís Meza more than expected).
Fields of papers citing papers by Luís Meza
This network shows the impact of papers produced by Luís Meza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís Meza. The network helps show where Luís Meza may publish in the future.
Co-authors
The 25 scholars most cited alongside Luís Meza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 20 | |
| 12 | 2022 | 12 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 2 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 9 | |
| 17 | 2021 | 18 | |
| 18 | 2021 | 6 | |
| 19 | 2021 | 16 | |
| 20 | Características clínicas y microscópicas de Candida albicans en pacientes con diabetes tipo 1 | 2013 | 0 |
About Luís Meza
Luís Meza is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Biotechnology and Internal Medicine, having authored 90 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (43 papers), Cancer Immunotherapy and Biomarkers (21 papers), Cancer Genomics and Diagnostics (16 papers), Bladder and Urothelial Cancer Treatments (12 papers), Pancreatic and Hepatic Oncology Research (11 papers), Renal and related cancers (10 papers), Economic and Financial Impacts of Cancer (8 papers) and Cancer Research and Treatments (8 papers). The work is most often cited by research in Oncology (951 citations), Hematology (294 citations), Dermatology (165 citations), Genetics (500 citations) and Clinical Biochemistry (88 citations). Luís Meza has collaborated with scholars based in United States, Canada and Denmark. Frequent co-authors include John A. Glaspy, Bertrand C. Liang, Frankie A. Holmes, Michael A. Savin, Joyce O’Shaughnessy, Stephen E. Jones, Theresa Neumann, J. Shogan, S. Vukelja and Lister Hill. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Clinical Genitourinary Cancer, Annals of Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.